McLauchlan G J, Handoll H H
Department of Orthopaedics, Princess Margaret Rose Orthopaedic Hospital, Edinburgh, UK, EH10 7ED.
Cochrane Database Syst Rev. 2001(2):CD000232. doi: 10.1002/14651858.CD000232.
Achilles tendinitis is one of the most common of all sports injuries. There is no consensus on treatment.
To assess the effectiveness of various treatment interventions for acute and chronic Achilles tendinitis in adults.
The Cochrane Musculoskeletal Injuries Group specialised register (December 2000), Cochrane Controlled Trials Register (The Cochrane Library Issue 4, 2000), MEDLINE (1966 to December 2000), EMBASE (1980 to 2001 wk 04), CINAHL (1982 to December 2000), and reference lists of identified trials were searched.
Randomised or quasi-randomised trials of treatment interventions for acute and chronic Achilles tendinitis in adults. Studies focusing on pathological tendinitis were excluded. Excluded were those trials that compared different dosages of the same drug or drugs within the same class of drugs, for example different non-steroidal anti-inflammatory drugs (NSAIDs).
Three reviewers independently assessed trial quality, by use of a ten item check list, and extracted data. Requests were sent for separate data for Achilles tendinitis patients in studies within trials of mixed patient populations. Where possible, quantitative analysis and limited pooling of data were undertaken.
Nine trials, involving 697 patients, met the inclusion criteria of the review. Methodological quality was adequate in most of the trials with regards to blinding but the assessment of outcome was incomplete and short-term. There was weak but not robust evidence from three trials of a modest benefit of NSAIDs for the alleviation of acute symptoms. There was some weak evidence of no difference compared with no treatment of low dose heparin, heel pads, topical laser therapy and peritendonous steroid injection, but this could not be fully evaluated from the reports of four trials. The results of an experimental preparation of a calf-derived deproteinized haemodialysate, Actovegin, were promising but the severity of patient symptoms was questionable in the single small trial testing this comparison. The results of a comparison of glycosaminoglycan sulfate with a NSAID were inconclusive.
REVIEWER'S CONCLUSIONS: There is insufficient evidence from randomised controlled trials to determine which method of treatment is the most appropriate for the treatment of acute or chronic Achilles tendinitis. Further research is warranted.
跟腱炎是所有运动损伤中最常见的损伤之一。对于其治疗尚无共识。
评估各种治疗干预措施对成人急性和慢性跟腱炎的有效性。
检索了Cochrane肌肉骨骼损伤小组专门注册库(2000年12月)、Cochrane对照试验注册库(《Cochrane图书馆》2000年第4期)、MEDLINE(1966年至2000年12月)、EMBASE(1980年至2001年第04周)、CINAHL(1982年至2000年12月)以及已识别试验的参考文献列表。
针对成人急性和慢性跟腱炎治疗干预措施的随机或半随机试验。排除专注于病理性跟腱炎的研究。排除那些比较同一类药物中不同剂量的同一药物或不同药物的试验,例如不同的非甾体抗炎药(NSAIDs)。
三位评价者使用一份包含十个条目的核对清单独立评估试验质量并提取数据。对于混合患者群体试验中的跟腱炎患者,要求提供单独的数据。在可能的情况下,进行了定量分析和有限的数据合并。
九项试验,涉及697名患者,符合本综述的纳入标准。在大多数试验中,方法学质量在盲法方面是足够的,但结局评估不完整且为短期评估。三项试验有微弱但不确凿的证据表明NSAIDs对缓解急性症状有一定益处。有一些微弱证据表明低剂量肝素、足跟垫、局部激光治疗和腱周类固醇注射与不治疗相比无差异,但从四项试验的报告中无法对此进行全面评估。一种源自小牛的脱蛋白血液透析液Actovegin的试验制剂结果很有前景,但在测试该比较的单个小型试验中,患者症状的严重程度存在疑问。硫酸糖胺聚糖与一种NSAID比较的结果尚无定论。
随机对照试验中没有足够的证据来确定哪种治疗方法最适合治疗急性或慢性跟腱炎。需要进一步研究。